These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3512613)

  • 21. Kidney pathology in liver allograft recipients after long-term treatment with cyclosporin A.
    Dische FE; Neuberger J; Keating J; Parsons V; Calne RY; Williams R
    Lab Invest; 1988 Apr; 58(4):395-402. PubMed ID: 3282124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphological patterns in cyclosporine-treated renal transplant recipients.
    Mihatsch MJ; Thiel G; Basler V; Ryffel B; Landmann J; von Overbeck J; Zollinger HU
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):101-16. PubMed ID: 3895652
    [No Abstract]   [Full Text] [Related]  

  • 23. The detection of renal allograft rejection by fine-needle intrarenal manometry.
    Wilson RG; Taylor RM; Proud G
    Br J Surg; 1985 Oct; 72(10):816-8. PubMed ID: 3899243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The diagnosis of cyclosporin nephrotoxicity in patients after kidney transplantation].
    Rozental' RL; Il'inskiĭ IM; Bitsans IaB; Strokan' VA
    Ter Arkh; 1990; 62(6):92-4. PubMed ID: 2218937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a therapeutic range for monitoring plasma cyclosporin in renal allograft recipients?
    Ubhi CS; Woodhouse L; Guillou PJ; Giles GR
    Nephrol Dial Transplant; 1988; 3(6):814-9. PubMed ID: 3147426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal lesions in ciclosporin A-treated kidney transplant patients.
    Banfi G; Imbasciati E; Fogazzi GB; Tarantino A
    Appl Pathol; 1987; 5(2):95-100. PubMed ID: 3307851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histopathological changes in cyclosporin-treated renal allografts biopsied at one and twelve months.
    Bignardi L; Neild GH; Hartley RB; Taube DH; Cameron JS; Rudge CJ; Williams DG; Ogg CS
    Nephrol Dial Transplant; 1987; 2(5):366-70. PubMed ID: 3122115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity.
    Yagisawa T; Omoto K; Shimizu T; Ishida H; Tanabe K
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():51-7. PubMed ID: 26031587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential diagnosis of Cyclosporin A nephrotoxicity versus rejection by fine needle aspiration biopsy.
    Häyry P; von Willebrand E; Ahonen J
    Proc Eur Dial Transplant Assoc; 1983; 20():356-61. PubMed ID: 6361749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tc-99m DTPA scans in renal allograft rejection and cyclosporine nephrotoxicity.
    Gedroyc W; Taube D; Fogleman I; Neild G; Cameron S; Maisey M
    Transplantation; 1986 Nov; 42(5):494-7. PubMed ID: 3538534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ARFI-based tissue elasticity quantification and kidney graft dysfunction: first clinical experiences.
    Stock KF; Klein BS; Cong MT; Regenbogen C; Kemmner S; Büttner M; Wagenpfeil S; Matevossian E; Renders L; Heemann U; Küchle C
    Clin Hemorheol Microcirc; 2011; 49(1-4):527-35. PubMed ID: 22214724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of cyclosporin A after antilymphocyte serum in renal transplantation].
    Hourmant M; Soulillou JP; Remi JP; Sagniez G; Guenel J
    Presse Med; 1985 Nov; 14(41):2093-6. PubMed ID: 2934708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of adhesion molecules in allograft renal dysfunction. A distinct diagnostic pattern in rejection and cyclosporine nephrotoxicity.
    Mampaso F; Sanchez-Madrid F; Marcen R; Molina A; Pascual J; Bricio T; Martin A; Alvarez V
    Transplantation; 1993 Sep; 56(3):687-91. PubMed ID: 8212167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Renal lesions induced by cyclosporin. Apropos of 4 renal biopsies and 22 necropsies of recipients of heart transplant].
    Chomette G; Auriol M; Beaufils H; Rottembourg A; Cabrol C
    Ann Pathol; 1986; 6(1):29-36. PubMed ID: 3521626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinguishing between renal allograft rejection and cyclosporin nephrotoxicity.
    Hrushesky WJ
    Lancet; 1985 Aug; 2(8453):501. PubMed ID: 2863520
    [No Abstract]   [Full Text] [Related]  

  • 36. Associations between cyclosporine therapy and interstitial fibrosis in renal allograft biopsies.
    Ruiz P; Kolbeck PC; Scroggs MW; Sanfilippo F
    Transplantation; 1988 Jan; 45(1):91-5. PubMed ID: 3276070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of cyclosporine A-induced nephrotoxicity from acute rejection in renal transplantation using fine-needle aspiration biopsies.
    Zannier A; Mutin M; Touraine JL; Traeger J
    Transplant Proc; 1987 Oct; 19(5):3630-2. PubMed ID: 3313874
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
    Diethelm AG
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum cyclosporine kinetic profile. Failure to correlate with nephrotoxicity or rejection episodes following sequential immunotherapy for renal transplantation.
    Sommer BG; Sing DE; Henry ML; Ferguson RM; Orosz CG
    Transplantation; 1988 Jan; 45(1):86-90. PubMed ID: 3276069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical markers of renal tubular injury and cyclosporin nephrotoxicity in kidney allograft biopsies.
    García Del Moral R; Navarro N; Montes A; Aguilar D; Aneiros J
    Nephron; 1992; 62(1):121-2. PubMed ID: 1436283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.